Kava

Common Names: kava, kava kava, awa, ava pepper, ava root, kawa
Latin Names: Piper methysticum
Background
- Kava is native to the South Pacific and is a member of the pepper family.
- Pacific Islanders have used kava beverages for thousands of years for ceremonial and medicinal purposes. More recently, the use of kava as a beverage has grown both in the Pacific Islands and in other parts of the world. Kava drinks are now sold at kava bars at many locations in the United States.
- Kava products are sold in the United States as dietary supplements and in some other countries as drugs or herbal medicines. These products are promoted for anxiety and other health conditions.
How Much Do We Know?
- There has been a fair amount of research in people on the use of kava for anxiety, but few studies have been done on other conditions.
- There has also been substantial investigation of rare but sometimes severe cases of liver injury associated with the use of kava.
What Have We Learned?
- Kava supplements may be helpful for anxiety, but they may need to be taken for several weeks to produce an effect. Kava does not appear to be helpful for symptoms of generalized anxiety disorder.
- There isn’t enough evidence to show whether kava is helpful for any other conditions.
What Do We Know About Safety?
- Various kava products have been linked to rare cases of liver injury, some of which have been serious or even fatal. The first reported cases involved medicinal or dietary supplement products that had been extracted with alcohol or acetone, but other cases have involved kava beverages prepared with water. It has been suggested that the use of undesirable varieties (cultivars) of kava plants or inappropriate parts of the plant may be responsible for liver toxicity; other possibilities include the consumption of kava together with alcohol and the adulteration or contamination of kava products. It has also been suggested that genetic differences among people might influence their susceptibility to liver toxicity and that consumption of kava in large amounts or for prolonged periods of time may increase risk.
- Kava can cause digestive upset, headache, dizziness, and other side effects. Long-term use of high doses of kava may cause kava dermopathy, a condition that involves dry, scaly, flaky skin with reddened eyes and temporary yellow discoloration of the skin, hair, and nails.
- Kava should not be used together with other substances that have sedative effects, such as benzodiazepines or alcohol. If you take any type of medicine, talk with your health care provider before using kava or other herbal products; some herbs and medicines interact in harmful ways.
- Kava may have special risks if taken during pregnancy or while breastfeeding because of the presence of harmful pyrone constituents.
Keep in Mind
- Take charge of your health—talk with your health care providers about any complementary health approaches you use. Together, you can make shared, well-informed decisions.
- Federal Regulation of Herbal Products
- Depending on what’s in them, how they’re intended to be used, and how they’re administered (orally or topically), herbal products are regulated in a variety of ways. Many herbal products intended for oral use are marketed as dietary supplements. The regulatory paths for making and distributing dietary supplements are different than those for drugs.
- Unlike drugs, dietary supplements are not approved by the U.S. Food and Drug Administration (FDA) before they are sold to the public. When public health concerns arise about the safety of a dietary supplement or an ingredient including an herb, the FDA can take action to protect the public. Manufacturers and distributors of supplements are responsible for evaluating the safety and labeling of their products before marketing to ensure that they meet all regulatory requirements.
NCCIH Clearinghouse
The NCCIH Clearinghouse provides information on NCCIH and complementary and integrative health approaches, including publications and searches of Federal databases of scientific and medical literature. The Clearinghouse does not provide medical advice, treatment recommendations, or referrals to practitioners.
Toll-free in the U.S.: 1-888-644-6226
Telecommunications relay service (TRS): 7-1-1
Website: https://www.nccih.nih.gov
Email: info@nccih.nih.gov (link sends email)
PubMed®
A service of the National Library of Medicine, PubMed® contains publication information and (in most cases) brief summaries of articles from scientific and medical journals. For guidance from NCCIH on using PubMed, see How To Find Information About Complementary Health Practices on PubMed.
Website: https://pubmed.ncbi.nlm.nih.gov/
Office of Dietary Supplements (ODS), National Institutes of Health (NIH)
ODS seeks to strengthen knowledge and understanding of dietary supplements by evaluating scientific information, supporting research, sharing research results, and educating the public. Its resources include publications (such as Dietary Supplements: What You Need To Know) and fact sheets on a variety of specific supplement ingredients and products (such as vitamin D and multivitamin/mineral supplements).
Website: https://ods.od.nih.gov
Email: ods@nih.gov (link sends email)
Key References
- Ballotin VR, Bigarella LG, Brandão ABM, et al. Herb-induced liver injury: systematic review and meta-analysis. World Journal of Clinical Cases. 2021;9(20):5490-5513.
- Bian T, Corral P, Wang Y, et al. Kava as a clinical nutrient: promises and challenges. Nutrients. 2020;12(10):3044.
- Food and Agriculture Organization of the United Nations/World Health Organization. Kava: a review of the safety of traditional and recreational beverage consumption. Technical report. 2016. Accessed at openknowledge.fao.org/items/ddb51a21-1451-4b4f-9c29-eaab9af1131b on May 31, 2024.
- Kava kava. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. Updated April 10, 2018. Accessed at ncbi.nlm.nih.gov/books/NBK548637 on May 30, 2024.
- Kava. NatMed Pro website. Accessed at naturalmedicines.therapeuticresearch.com on April 24, 2024. [Database subscription].
- Kuchta K, Schmidt M, Nahrstedt A. German kava ban lifted by court: the alleged hepatotoxicity of kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Medica. 2015;81(18):1647-1653.
- Mamallapalli J, Kanumuri SRR, Corral P, et al. Characterization of different forms of kava (Piper methysticum) products by UPLC-MS/MS. Planta Medica. 2022;88(14):1348-1349.
- Sarris J, Byrne GJ, Bousman CA, et al. Kava for generalised anxiety disorder: a 16-week double-blind, randomised, placebo-controlled study. Australian & New Zealand Journal of Psychiatry. 2020;54(3):288-297.
- Soares RB, Dinis-Oliveira RJ, Oliveira NG. An updated review on the psychoactive, toxic and anticancer properties of kava. Journal of Clinical Medicine. 2022;11(14):4039.
- Teschke R, Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. JAMA. 2010;304(19):2174-2175.
- Teschke R, Sarris J, Schweitzer I. Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. British Journal of Clinical Pharmacology. 2012;73(2):170-174.
- U.S. Food and Drug Administration. Memorandum. Review of the published literature pertaining to the safety of kava for use in conventional foods. August 11, 2020. Accessed at www.fda.gov/media/169556/download on May 31, 2024.
- Verma K, Singh D, Srivastava A. The impact of complementary and alternative medicine in insomnia: a systematic review. Cureus. 2022;14(8):e28425.
- White CM. The pharmacology, pharmacokinetics, efficacy, and adverse events associated with kava. Journal of Clinical Pharmacology. 2018;58(11):1396-1405.
This publication is not copyrighted and is in the public domain. Duplication is encouraged.
NCCIH has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by NCCIH.